Pediatric anesthesia & critical care

Effect of General Anesthesia Combined with Single-Shot, Single-Level Thoracic Paravertebral Block on Postoperative Analgesia in Children Undergoing Thoracoscopic Mediastinal Tumor Resection: A Randomized Controlled Trial

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Primary result · AUC-FLACCResult — go to the resultMean difference −11.8 95% CI −14.2 to −9.34

Authors' conclusion

Single-shot, single-level TPVB provides early postoperative analgesia in pediatric thoracoscopic mediastinal tumor surgery, enhances short-term recovery, reduces opioid requirements, and does not increase hospital costs or adverse events.

Study context

Population
Children aged 4 to 12 years scheduled for thoracoscopic mediastinal tumor resection
Participants
50 vs 51
Comparison
GA plus preincision ultrasound-guided thoracic paravertebral block (TPVB) vs GA alone
  • Gn = 50reference
  • Tn = 51
Primary endpoint
Pain intensity, AUC of Face, Legs, Activity, Cry, and Consolability (FLACC) scores (AUC-FLACC)
Follow-up
First 24 hours
Methodological detailsprospective, single-centre
  • Prospective
  • Single-centre

Primary result

AUC-FLACC

Mean difference

−11.8

95% CI −14.2 to −9.34

P < 0.001

By group

T

41.3/240

G

53.0/240

T vs G
mean difference −11.8 (95% CI −14.2 to −9.34); P < 0.001

As reported in the abstract

Secondary outcomes

Pain scores · first 20 hours

Lower in group T

Questionnaire (QoR-15) scores · 24 hours

Higher in group T

Intraoperative anesthetic use, postoperative rescue opioids, hospital stay

All reduced in group T

Original publication

Effect of General Anesthesia Combined with Single-Shot, Single-Level Thoracic Paravertebral Block on Postoperative Analgesia in Children Undergoing Thoracoscopic Mediastinal Tumor Resection: A Randomized Controlled Trial. J Cardiothorac Vasc Anesth. Published 15 April 2026. doi:10.1053/j.jvca.2026.04.025

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.